文献速递消化道肿瘤与早癌消化内镜

结直肠腺瘤蛋白质组学分析识别异时性进展期结直肠肿瘤发生的预测风险特征

Proteomic Profiling of Colorectal Adenomas Identifies a Predictive Risk Signature for Development of Metachronous Advanced Colorectal Neoplasia.
PubMed 文献 · Gastroenterology · 2023-03-24

研究对丹麦国家筛查项目中98例高级别腺瘤石蜡样本进行质谱蛋白质组学与机器学习分析,按随访结局分为无新生进展期肿瘤组(G0,45例)和异时性进展期肿瘤组(G1,53例)。结果显示约5000种蛋白的丰度信息足以预测高级别腺瘤或结直肠癌的未来发生。

要点

  • 基于质谱的蛋白质组学联合机器学习可分析甲醛固定石蜡包埋高级别腺瘤样本。
  • 约5000种蛋白的丰度信息足以区分无新生与异时性进展期肿瘤两组。
  • 蛋白质组特征可在异时性进展期病变发生前数年预测其发生。

核心结论

  • 对98例切除腺瘤样本的定量蛋白质组学数据深入分析发现,其蛋白质组可在异时性进展期病变发生前数年预测其发生与进展。

研究设计与样本

  • 采用基于质谱的蛋白质组学联合机器学习分析,对丹麦国家筛查项目中具有长期临床随访的甲醛固定石蜡包埋高级别腺瘤样本进行蛋白质组学分析。
  • 共分析98例选定的高级别腺瘤样本,包括20例技术重复;其中45例属于无新生进展期肿瘤组(G0),53例属于异时性进展期肿瘤组(G1)。
  • G0组为息肉切除术后10年内无新发高级别腺瘤或结直肠癌;G1组为诊断后5年内发生新的高级别腺瘤或结直肠癌。

主要发现

  • 在均匀流形近似与投影图中两组清晰区分,表明约5000种蛋白的丰度信息足以预测未来高级别腺瘤发生或结直肠癌发展。
  • 研究从98例选定高级别腺瘤样本(含20例技术重复)中生成蛋白质组数据集。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Colonic adenomatous polyps, or adenomas, are frequent precancerous lesions and the origin of most cases of colorectal adenocarcinoma. However, we know from epidemiologic studies that although most colorectal cancers (CRCs) originate from adenomas, only a small fraction of adenomas (3%-5%) ever progress to cancer. At present, there are no molecular markers to guide follow-up surveillance programs. METHODS: We profiled, by mass spectrometry-based proteomics combined with machine learning analysis, a selected cohort of formalin-fixed, paraffin-embedded high-grade (HG) adenomas with long clinical follow-up, collected as part of the Danish national screening program. We grouped subjects in the cohort according to their subsequent history of findings: a nonmetachronous advanced neoplasia group (G0), with no new HG adenomas or CRCs up to 10 years after polypectomy, and a metachronous advanced neoplasia group (G1) where individuals developed a new HG adenoma or CRC within 5 years of diagnosis. RESULTS: We generated a proteome dataset from 98 selected HG adenoma samples, including 20 technical replicates, of which 45 samples belonged to the nonmetachronous advanced neoplasia group and 53 to the metachronous advanced neoplasia group. The clear distinction of these 2 groups seen in a uniform manifold approximation and projection plot indicated that the information contained within the abundance of the ∼5000 proteins was sufficient to predict the future occurrence of HG adenomas or development of CRC. CONCLUSIONS: We performed an in-depth analysis of quantitative proteomic data from 98 resected adenoma samples using various novel algorithms and statistical packages and found that their proteome can predict development of metachronous advanced lesions and progression several years in advance.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Bech JM, Terkelsen T, Bartels AS, et al. Proteomic Profiling of Colorectal Adenomas Identifies a Predictive Risk Signature for Development of Metachronous Advanced Colorectal Neoplasia. Gastroenterology. 2023. PMID: 36966943. doi:10.1053/j.gastro.2023.03.208

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。